You
LT

Lyra Therapeutics, Inc.

Company · Health · MA
Statements1
Sightings1
Years covered2025 – now
Primary sourceSEC Form 10-K
All statements
2025 – nowCurrentOur mission is to transform the ear, nose and throat ("ENT") treatment paradigm by utilizing our proprietary technology to develop safe and effective therapies for the treatment of CRS.Mission · Innovation · SEC Form 10-K, filed 2025-03-13
Organization
Type
Company
Industry
Health
Location
MA, US
Size
—
Website
—
Status
active
All filings on SEC EDGAR ↗